VVP
CVS icon

Venture Visionary Partners’s CVS Health CVS Stock Holding History

Venture Visionary Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
10,185
+73
+0.7% +$6.52K 0.03% 336
2026
Q1 		$726K Buy
10,112
+609
+6% +$46.9K 0.02% 362
2025
Q4 		$754K Sell
9,503
-522
-5% -$41.2K 0.02% 361
2025
Q3 		$756K Buy
10,025
+9
+0.1% +$617 0.03% 337
2025
Q2 		$691K Buy
10,016
+3
+0% +$197 0.03% 338
2025
Q1 		$678K Sell
10,013
-154
-2% -$9.22K 0.03% 330
2024
Q4 		$456K Sell
10,167
-3,707
-27% -$208K 0.02% 389
2024
Q3 		$872K Sell
13,874
-1,113
-7% -$64.9K 0.04% 290
2024
Q2 		$885K Buy
14,987
+309
+2% +$19.3K 0.04% 287
2024
Q1 		$1.17M Buy
14,678
+140
+1% +$10.7K 0.06% 257
2023
Q4 		$1.15M Buy
14,538
+39
+0.3% +$2.78K 0.06% 239
2023
Q3 		$1.01M Buy
14,499
+16
+0.1% +$1.13K 0.06% 244
2023
Q2 		$1M Sell
14,483
-557
-4% -$39.6K 0.06% 243
2023
Q1 		$1.12M Sell
15,040
-680
-4% -$57K 0.07% 216
2022
Q4 		$1.46M Sell
15,720
-11
-0.1% -$1.06K 0.11% 169
2022
Q3 		$1.5M Buy
15,731
+583
+4% +$57.7K 0.12% 148
2022
Q2 		$1.4M Buy
15,148
+402
+3% +$39.2K 0.11% 159
2022
Q1 		$1.49M Sell
14,746
-266
-2% -$27.9K 0.1% 172
2021
Q4 		$1.54M Buy
15,012
+1,034
+7% +$95.5K 0.1% 170
2021
Q3 		$1.19M Sell
13,978
-3,553
-20% -$298K 0.08% 190
2021
Q2 		$1.46M Sell
17,531
-5,815
-25% -$476K 0.12% 162
2021
Q1 		$1.76M Buy
23,346
+3,047
+15% +$222K 0.15% 129
2020
Q4 		$1.39M Buy
20,299
+15,921
+364% +$1.04M 0.15% 115
2020
Q3 		$270K Buy
+4,378
New +$272K 0.07% 158

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Venture Visionary Partners's CVS Position: Q2 2026 in Review

Venture Visionary Partners increased its CVS Health (CVS) stake by 0.72% in Q2 2026, buying an estimated $6.52K and bringing the position to 10,185 shares worth $1.05M. The position accounts for 0.03% of the portfolio, ranked #336.

Venture Visionary Partners first reported a position in CVS in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.76M in Q1 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Venture Visionary Partners held 10,185 shares of CVS Health worth $1.05M as of Q2 2026.
  • Venture Visionary Partners bought 73 CVS Health shares in Q2 2026, an estimated $6.52K.
  • CVS Health made up 0.03% of Venture Visionary Partners's portfolio in Q2 2026, its #336 holding.
  • Venture Visionary Partners first reported a position in CVS Health in Q3 2020 and has held it in 24 quarters since.
  • Venture Visionary Partners's CVS Health position peaked at $1.76M in Q1 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Venture Visionary Partners's 13F filing for Q2 2026, filed 27 Jul 2026.